Nouvelles de la Bourse
Dernières actualités financières · Mis à jour Jul 24, 2026
Keefe Bruyette maintient une note Outperform sur Dave Inc. (DAVE)
Keefe Bruyette Maintains an Outperform Rating on Dave Inc. (DAVE)
The panelists agree that Dave Inc. has demonstrated strong Q1 results but express concerns about the sustainability of its growth …
Citi conserve une note Neutre sur Universal Display Corporation (OLED)
Citi Retains Neutral Rating On Universal Display Corporation (OLED)
The panel generally agrees that OLED is facing significant challenges, including a 14% revenue contraction, 44% drop in net income, …
Le PDG de Chevron prévient d'une crise pétrolière des années 1970. Ces 3 actions énergétiques pourraient grimper avant l'été.
Chevron's CEO Is Warning of a 1970s-Style Oil Crisis. These 3 Energy Stocks Could Surge Before Summer.
The panel discusses the potential impacts of a Hormuz closure on oil prices and energy stocks, with mixed views on …
3 erreurs de sécurité sociale que les couples mariés continuent de commettre en 2026
3 Social Security Mistakes Married Couples Are Still Making in 2026
While delaying the higher earner's Social Security claim to maximize survivor benefits can be mathematically sound, it exposes households to …
Ripple conclut des accords bancaires chaque semaine : pourquoi les détenteurs de XRP n'en voient pas les bénéfices
Ripple Is Closing Bank Deals Every Week: Why XRP Holders Aren’t Seeing the Benefit
The panel generally agrees that Ripple's success in institutional adoption and stablecoin (RLUSD) growth does not translate to XRP token …
Le géant de la vente au détail en centre commercial ferme son dernier magasin dans une ville clé après 26 ans
Mall retail giant closes final store in key city after 26 years
Despite positive trends like 7% Gap brand growth and 39% digital penetration, the panel is concerned about Athleta's 10% decline …
AMD vient d'atteindre un sommet historique -- Est-il trop tard pour acheter ?
AMD Just Hit an All-Time High -- Is it Too Late to Buy?
The panel discusses AMD's record-breaking quarter, with concerns around valuation, supply chain constraints, and demand visibility. The key debate revolves …
Acuta Capital parie sur Erasca (ERAS) et les traitements ciblés contre le cancer avec un achat de 354 575 actions
Acuta Capital Bet on Erasca (ERAS) and Targeted Cancer Treatments With a 354,575 Share Buy
Despite Acuta Capital's significant investment, the panel is largely bearish due to ERAS-0015 trial's patient death, high cash burn rate, …
Kailera Therapeutics est-elle un achat après son introduction en bourse spectaculaire ?
Is Kailera Therapeutics a Buy After Its Sizzling IPO?
Kailera Therapeutics' IPO is considered high-risk due to intense competition, lack of approved products, and substantial clinical and regulatory risks. …
Le titre LegalZoom est-il un achat après que le PDG ait acheté 125 000 actions ?
Is LegalZoom Stock a Buy After the CEO Purchased 125,000 Shares?
Despite a CEO buy signal, the panel is largely bearish due to LegalZoom's eroding moat from AI disruption, anemic margins, …
Greg Abel achète des actions de ce qui est probablement l'action préférée de Warren Buffett. Devriez-vous l'acheter aussi ?
Greg Abel Is Buying Shares of What Is Probably Warren Buffett's Favorite Stock. Should You Buy It Too?
Panelists generally agree that Berkshire Hathaway's current cash hoard and buyback activity signal a defensive posture rather than a growth …
Patient Square parie gros sur Nektar Pharmaceuticals (NKTR) en achetant 210 000 actions
Patient Square Makes a Big Bet on Nektar Pharmaceuticals (NKTR) Purchasing 210,000 Shares
Panelists generally agree that Patient Square's investment in NKTR signals confidence in Rezolve-AD's Phase 2b results, but they caution about …